Clinical Trial Update: Type III Dysbetalipoproteinemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Hyperlipoproteinemia Type III sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type Iii

Snippet

Sponsor: AstraZeneca | Conditions: Hyperlipoproteinemia Type III | Phase 3 | Status: COMPLETED